Harris FRC

UCB Group has chosen Daiichi Sankyo Co. Ltd. as its new commercial partner in Japan for an epilepsy drug, building on an existing relationship in the allergy area. The two firms have agreed to c

Glenmark , Ranbaxy Laboratories , Sun Pharma and other India drug makers are among 15 sued in a U.S. federal court for violating the patent of the epilepsy drug Vimpat (lacosamide) licensed to U

Schwarz Pharma AG is on a roll. Pfizer Inc. 's acquisition of worldwide rights to Schwarz's registration-stage incontinence product fesoterodine for $210 million plus royalties is the most recent